07th February 2022 | Pharma Updates
Show Data on Faropenem Sodium Extended Release Tablets: CDSCO tells Sun Pharma
This came after the drug major submitted its request to market faropenem sodium extendedrelease tablets 300 mg coupled with Bioequivalence report.
Mix and Match of Vaccine: Bharat Biotech
Bharat Biotech will evaluate the protection given by a combination of intranasal vaccine, Covishield and Covaxin.
Singapore Clears Trodelvy
Everest Medicine’sTrodelvy is indicated for the therapy of grownup patients with unresectable locally advanced or metastatic triple-negative breast cancer who have gotten at least two prior systemic therapies, one of them for metastatic disease.
YPB signs trial with Israeli firm
YPB has inked a third commercial trial of its MotifMicro1 with Latent Image Technology.
SA's First Corona Vaccine Plant
Merely 10% of Africans are vaccinated with the Covid vaccine.
Celltrion toStart GlobalClinical Trials for Inhaled Treatment
As of now, Celltrion has proved the safety of its inhaled Covid vaccine through a first phase clinical trial.
Flora Growth Seeks EUA In Colombia
This would be the first cannabisbased product to prevent Covid infection.
Chong Kun Dang Starts Investing Heavily In R&D
The company’s Research and Development investment crossed 100 bn won in the initial three-quarters of last year.
Novel research study to help children with MMPSI
A study from the University of South Australia may help kids suffering from malignant migrating partial seizures in infancy.
Don't Use Anti-choking Device on Kids: UK
According to the Medicines and Healthcare products Regulatory Agency, these devices should only be used by HCWs.
